Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2006 / Cilt: 40 - Sayı: 3

Childhood vitiligo: Epidemiology and etiology

Çocuklarda vitiligo: Epidemiyoloji ve etyoloji

Pages
81–86
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hereby we evaluate and discuss the epidemiologic and etiologic characteristics of the childhood vitiligo in the view of the recent relevant literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Childhood vitiligo shows different characteristics than that of adulthood in clinical types, primary localisation, association with autoimmune disorders and many other subjects.
📊
Key Findings & Data:Despite the presence of many new theories and classical ones that try to define the reasons of the disease, the etiology of vitiligo is still a subject of discussion.
💡
Conclusion & Impact:Hereby we evaluate and discuss the epidemiologic and etiologic characteristics of the childhood vitiligo in the view of the recent relevant literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Childhood vitiligo shows different characteristics than that of adulthood in clinical types, primary localisation, association with autoimmune disorders and many other subjects. Despite the presence of many new theories and classical ones that try to define the reasons of the disease, the etiology of vitiligo is still a subject of discussion. It is accepted that the disease occurs following a complex process including many factors. Hereby we evaluate and discuss the epidemiologic and etiologic characteristics of the childhood vitiligo in the view of the recent relevant literature.

Özet

Çocukluk çağında ortaya çıkan vitiligo; hastalığın klinik tipi, başlangıç yeri, otoimmün hastalıklar ile birlikteliği gibi birçok konuda erişkin vitiligosundan farklı özellikler göstermektedir. Vitiligonun etyolojisi, hastalığın nedenlerini ortaya koymaya çalışan klasik teoriler ve birçok yeni teorinin varlığına rağmen hala tartışma konusudur. Hastalığın, birçok faktörün katıldığı kompleks bir sürecin sonunda ortaya çıktığı görüşü hakimdir. Bu makalede, çocuklarda ortaya çıkan vitiligoya ait epidemiyolojik özellikler ve vitiligonun etyolojisi yeni görüşler ışığında değerlendirilmiştir.

🔖

Cite This Article

BAHADIR, S., YAYLI, S. (2022). Childhood vitiligo: Epidemiology and etiology. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 40 - Sayı: 3, 81–86. https://ajindex.com/articles/622174

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y: Vitiligo. Dermatology in General Medicine. Ed. Fitzpatrick TB- Freedberg IM, Eisen AZ, Wollf K
  2. Baskı. New York, McGraw-Hill,1999;949-960
  3. Odom RB, James WD, Berger TG: Andrews' Diseases of the Skin, 9.Baskı. Philadelphia, W.B.Saunders Company, 2000;1057-1068
  4. Haider RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA: Childhood vitiligo. J Am Acad Dermatol 1987;16:948-954
  5. Jaisankar TJ, Baruah MC, Garg BR: Vitiligo in children. Int J Dermatol 1992;31: 621-623
  6. Haider RM: Childhood vitiligo. Clin Dermatol 1997; 15:899-906
  7. Handa S, Dogra S: Epidemiology of childhood vitiligo: a study of 625 patients from North India.Pediatric Dermatol 2003;20:207-210
  8. Finco O, Cuccia M, Matinetti M: Age of onset in vitiligo: Relationship with HLA supratypes. Clin Genet 1991;39:48-54
  9. Tastan HB, Akar A, Orkunoğlu FE, Arca E, İnal A: Association of HLA Class 1 antigens and HLA Class 2 alleles with vitiligo in a Turkish population. Pigment Cell Res 2004;17:181-184
  10. Ongenae K,Van Geel N, Naeyaert JM: Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003; 16:90-100
  11. Schallreuter KU, Lemke R, Brandt O, Schwartz R: Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 1994; 188:269-275
  12. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M: High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994;74:120-123
  13. Bystryn JC: Serum antibodies in vitiligo patients. Clin Dermatol 1989;7:136-145
  14. Naughton GK, Eisinger M, Bystryn JC: Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983;81:540-542
  15. Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrud B, Yecheskel G, Youini P, Fishman P: Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp İmmunol 1996; 105:84-88
  16. Kemp EH, Gawkrodger DJ, MacNeil S, Watson PF: Detection of tyrosinase autoantibodies in patients with vitiligo using 35 S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol 1997;109:69-73
  17. Kemp EH, Gawkrodger DJ, Watson PF: Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2(TRP-2). Clin Exp Immunol 1997; 109:495-500
  18. Lang KS, Caroli CC, Muhm A: HLA-A2 restricted, melanocyte-specific CD8(+) T lymp